Inspiringly, we found miR-26a-5p regulated DNMT3A expression to remold DNA methylation pattern of SFRP1, therefore, modulated tumor growth and cancer stem cell-like properties via Wnt/β-catenin signaling pathway. The gene discussed is DNMT3A; the disease is cancer.